Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies. [PDF]
Ojala VK +15 more
europepmc +1 more source
The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. [PDF]
Gryksa K +4 more
europepmc +1 more source
X-ray crystal structure and in silico investigation of Tetrabromo thia-bridged diquinoline including anticancer mechanisms via target prediction and molecular docking. [PDF]
Alshahateet SF +4 more
europepmc +1 more source
Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma. [PDF]
Silva FN +7 more
europepmc +1 more source
Construction of lactate-myeloid-related prognostic risk model and prediction of immune-excluded microenvironment in gastric cancer via integrated scRNA-Seq and bulk RNA-Seq. [PDF]
Han X +8 more
europepmc +1 more source
Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network. [PDF]
Hellyer NJ +3 more
europepmc +1 more source
Immune responses to all ErbB family receptors detectable in serum of cancer patients
Employing NIH3T3 transfectants with individual human ErbB receptor coding sequences as recombinant antigen sources, we detected by immunoblot analysis specific immunoreactivity against all four ErbB receptors among 13 of 41 sera obtained from patients ...
Vincenzo Visco +2 more
exaly +2 more sources
ErbB receptors and tetraspanins: Casting the net wider [PDF]
Fedor Berditchevski
exaly +3 more sources
Related searches:
ErbB receptors and their ligands in the breast
Expert Reviews in Molecular Medicine, 2006ErbB receptor tyrosine kinases are membrane-bound receptors that possess intrinsic, ligand-activated, tyrosine kinase activity. Binding of growth factors to these receptors induces the formation of ErbB homo- and heterodimers and initiates a signalling cascade that traverses the cytoplasm to communicate with the nucleus and the cytoskeleton. The effect
openaire +2 more sources

